Hisham Shiblaq - Jun 10, 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Signature
/s/ Jonathan Stone, Attorney-in-Fact for Hisham Shiblaq
Stock symbol
PRCT
Transactions as of
Jun 10, 2024
Transactions value $
-$1,658,729
Form type
4
Date filed
6/12/2024, 06:44 PM
Previous filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $119K +26K +46.63% $4.56* 81.9K Jun 10, 2024 Direct F1
transaction PRCT Common Stock Sale -$1.78M -26K -31.8% $68.24 55.9K Jun 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -26K -17.9% $0.00 119K Jun 10, 2024 Common Stock 26K $4.56 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/9/2024.
F2 The Stock option was granted on April 5, 2019 and vested 10/46th on the ten month anniversary of the vesting commencement date of March 25, 2019 and the remaining vested monthly over a three year period thereafter.